A 36-year-old woman with primary biliary cirrhosis (PBC)-CREST (calcinosis, Raynaud's phenomenon, esophageal dysfunction, sclerodactyly and telangiectasia) overlap syndrome complicated by Sjogren's syndrome and arthritis is reported. She had suffered from Raynaud's phenomenon, sclerodactyly, morning stiffness, arthralgia and sicca symptomssince 34 years of age. She exhibited an increased level of alkaline phosphatase and hyperglobulinemia at 2.8 g/dl without any symptoms, and histological findings from the biopsy specimen of the liver were consistent with those of PBC. Her human leukocyte antigen (HLA) typing was DR8homozygous. (Internal Medicine 34: 451-454, 1995) 
Introduction
Complications of autoimmune diseases such as Sjogren's syndrome in patients with PBChave been described. Recently, CREST syndrome, one of the varieties of progressive systemic sclerosis (PSS), has been noted to associate with PBC. Arthritis with bone destruction is one of the findings in PSS, but not in CRESTsyndrome. HLADR9 is frequently found in Japanese patients with PBC-CRESToverlap syndrome (1) . We describe here a Japanese womanwith PBC-CREST overlap syndrome complicated further by Sjogren ' s syndrome and arthritis , whose HLAtype was homozygoushaplotype of DR8.
Case Report
A 36-year-old Japanese womanhad suffered from Raynaud' s phenomenon, sclerodactyly, morning stiffness, arthralgia and dry mouth for 2 years. At the age of 35, an increased serum level of alkaline phosphatase of 450 IU/1 was noted from tests conducted at Takebayashi Hospital in Iwaki district. No history of blood transfusion, alcohol or drug abuse was noted. She was admitted to our hospital for further investigation of liver dysfunction in April 1993 at 36 years of age.
On admission, severe telangiectasia of both hands and swelling of the left wrist and the right index finger were noted. No hepato-splenomegaly or jaundice was observed. Laboratory data showed an increased erythrocyte sedimentation rate of42 mm/hour. Hypochronic anemia with hemoglobin at 1 0.7 g/dl, white blood cell count at 5 ,200/mm3 and eosinophils at 12%were noted. Results of liver function tests were as follows: alanine transaminase level of 1 9 IU/1 (normal 6-29 IU/ 1), serum aspartate transaminase level of 22 IU/1 (normal 1 0-30 IU/1), alkaline phosphatase level of 687 IU/1 (normal 125-335 IU/1), gamma glutamyl transpeptidase level of 94 IU/1 (normal 6-30 IU/1), leucine aminopeptidase level of 146 IU/1 (normal 40-75 IU/1), cholinesterase level of 269 IU/1 (normal 200-^60 IU/1), serum bilirubin level of 0.5 mg/dl, serum hyaluronic acid level of 102 ng/ml (normal <50 ng/ml), serum albumin level of 3.5 g/dl and cholesterol level of 117 mg/dl. Serum immunoglobulin G, A and Mlevels were increased to 2140, 538 and 362 mg/dl, respectively. Results of serological tests were as follows: positive for rheumatoid factor at a titer of 40 U/ml, antimitochondrial antibody at a titer of 1 : 80, anti-M2 antibody at a titer of 850 U/ml, antinuclear antibody at a titer of 1:640 with speckled and discrete speckled pattern, anticentromere antibody at a titer of 22.3 cutoff index; and negative for antibodies to Scl-70, SS-A, SS-B, DNAand smooth muscle. Viral markers for hepatitis B or hepatitis C were all negative. Xray findings of the right hand showed destruction of the second and the third metacarpal bones (Fig. 1) . Histopathology of the liver specimen obtained by needle biopsy indicated an inflammation of the portal tract and damaged interlobular bile duct as shown in Fig. 2A . The number of bile ducts was also decreased. Histological findings did not show typical chronic non-suppurative destructive cholangitis; rather, findings were compatible with those of PBC.
Decreased excretion of tears at 4 mmwetting in Schirmer's test, decreased excretion of saliva at 10 ml in 30 min in the gum test, and massive infiltration of lymphocytes in biopsy specimen of salivary glands in lip as shown in Fig. 2B present patient showed complication of not only Sjogren's syndrome but also arthritis with bone destruction. Acrolysis was found in 3 of 14 (21%) patients with PBC-CRESToverlap syndrome and destructive arthropathy was found in 4 of 83 (4.8%) patients with PBC (23). Bone destruction, resembling rheumatoid arthritis, is seen in a few PSS patients with diffuse cutaneous scleroderma (24). Arthritis and Sjogren' s syndrome as well as CRESTsyndrome were occasionally seen in patients with anticentromere antibodies (25). Based on these observations, Nishikai proposed a new syndrome, i.e., CRESTAS (CREST+Arthritis+Sjogren's syndrome), in 1986 (26) . Following his proposal, the present patient could be diagnosed as having asymptomatic PBC-CRESTAS (RSTAS) overlap syndrome, which to our knowledgehas been never reported. HLAAl and B8 were found in 5 of 10 (50%) non-Japanese patients with PBC-CRESToverlap syndrome (23), but there is no literature on the HLADRlocus in PBC-CRESToverlap syndrome in non-Japanese patient. HLADR9was found in 9 of 18 (50%) Japanese patients with PBC-CREST overlap syndrome and DR8 was also found in 8 of 18 (44.4%) Japanese patients with this syndrome ( Further studies on patients with PBC-CRESTAS overlap syndrome are necessary to verify the association of HLADR8with this overlap syndrome. The present patient's HLADR8ho-mozygosity was due to the consanguinity of her parents and might have increased the relative risk for occurrence of this PBC-CRESTASoverlap syndrome.
